ChemPion
Latest round
- Series C
Last raised
- Feb 2026
Total raised
- $14M
Investors
- 10
About ChemPion
, Ltd, trading as ChemPion, is a biotech company that focuses on building a pharmaceutical industrialization innovation platform. In 2019, the company launched the CMC platform for small molecule preparations in Zhengzhou Linkong Biomedical Park. It has set up 4 R&D centers in Beijing, Nanjing, Suzhou, and Chongqing, and is building a 100-mu GMP production base for green APIs in Fuyang, Anhui. The company's main products include continuous flow and enzyme-catalyzed production technology platforms for APIs, pharmaceutical intermediates, APIs and intermediates, etc. APIs and intermediates include 2-(1-Methylcyclopropyl) acetic acid and 6-Bromonaphthalen-2-amine, etc. It also provides services such as drug CMC research and development, technology transfer, registration application, industrialization, etc. The company's revenue is generated by providing continuous flow and enzyme-catalyzed production technology platforms for APIs, pharmaceutical intermediates, APIs and intermediates, etc.
Who invested in ChemPion
10 investors across 4 rounds
See all investors in ChemPion
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ChemPion
Who invested in ChemPion?
ChemPion has 10 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ChemPion raised?
ChemPion has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did ChemPion last raise money?
ChemPion's most recent round on record is a Series C, in Feb 2026.
What does ChemPion do?
, Ltd, trading as ChemPion, is a biotech company that focuses on building a pharmaceutical industrialization innovation platform.
Where is ChemPion headquartered?
ChemPion is headquartered in Beijing, China.
Which VCs invest in companies like ChemPion?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at ChemPion's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like ChemPion? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.